Search Within

Tiffany A Traina

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (49)
  2. Journal Article (34)
  3. Guidelines (1)
  4. Review (1)
Groups
  1. Biostatistics Service (85)
  2. Breast Medicine Service (85)
  3. Department of Medicine (85)
  4. Epidemiology and Biostatistics (85)
  5. Solid Tumor Oncology Division (85)
  6. Survivorship Research (85)

More Groups

People
  1. Sujata Patil (62)
  2. Clifford Hudis (47)
  3. Larry Norton (33)
  4. Ayca Gucalp (24)
  5. Chau Dang (20)
  6. Mark Robson (20)

More People

Years
  1. 2024 (5)
  2. 2023 (3)
  3. 2022 (5)
  4. 2021 (4)
  5. 2020 (4)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (25)
  2. Cancer Research (15)
  3. Breast Cancer Research and Treatment (7)
  4. Clinical Cancer Research (4)
  5. International Journal of Radiation Oncology, Biology, Physics (4)
  6. Annals of Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (25)
  2. American Association for Cancer Research (19)
  3. Springer (13)
  4. Elsevier Inc. (10)
  5. Oxford University Press (4)
  6. John Wiley & Sons (3)

More Publishers

Results (85)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)(+) metastatic breast cancer (MBC): Pharmacokinetics (PK)
    Meeting Abstract

    Gucalp, A.; Corben, A.; Patil, S.; Boyle, L. A.; Hudis, C.; Traina, T. A.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: Overall survival and updated progression-free survival results from a phase II study
    Journal Article

    Smyth, L. M.; Iyengar, N. M.; Chen, M. F.; Popper, S. M.; Patil, S.; Wasserheit-Lieblich, C.; Argolo, D. F.; Singh, J. C.; Chandarlapaty, S.; Sugarman, S. M.; more...
    Breast Cancer Research and Treatment (2016)

    Fulltext@MSK | Save
  • Androgen receptor (AR) mutations in a cohort of patients with breast cancer (BC) who have undergone tumor genomic profiling
    Meeting Abstract

    Gucalp, A.; Proverbs-Singh, T. A.; Razavi, P.; Chandarlapaty, S.; Patil, S.; Ross, D. S.; Zehir, A.; Baselga, J.; Hudis, C. A.; Traina, T. A.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • A phase 1/2 study of once-daily oral VT-464 in patients with advanced androgen receptor (AR) positive triple negative (TNBC) or estrogen receptor (ER) positive breast cancer (BC)
    Meeting Abstract

    Gucalp, A.; Hudis, C.; Norton, L.; Patil, S.; Kurman, M. R.; Eisner, J. R.; Moore, W. R.; Traina, T. A.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • A pilot study of dose-dense paclitaxel with trastuzumab and lapatinib for node-negative HER2-overexpressed breast cancer
    Journal Article

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S. M.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G. M.; Drullinsky, P. R.; Gajria, D.; Goldfarb, S. B.; Comen, E. A.; more...
    Clinical Breast Cancer (2016)

    Fulltext@MSK | Save
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • TBCRC 019: A phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 monoclonal antibody tigatuzumab in patients with triple-negative breast cancer
    Journal Article

    Forero-Torres, A.; Varley, K. E.; Abramson, V. G.; Li, Y.; Vaklavas, C.; Lin, N. U.; Liu, M. C.; Rugo, H. S.; Nanda, R.; Storniolo, A. M.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prevalence of hypomagnesemia in patients with HER2-positive breast cancer receiving pertuzumab treatment
    Meeting Abstract

    Proverbs-Singh, T. A.; Cadoo, K. A.; Torre, G.; Patil, S.; Gucalp, A.; Dang, C. T.; Hudis, C. A.; Glezerman, I. G.; Traina, T. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I/II study of neratinib plus temsirolimus in HER2+ metastatic breast cancer reveals ongoing HER2 pathway dependence in many patients despite several lines of HER2 targeted therapy
    Meeting Abstract

    Gajria, D.; Modi, S.; Saura, C.; Sakr, R.; Solano, K.; Won, H.; Pannu, H.; Patil, S.; Lake, D.; Traina, T.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save